Senate Committee Grilling Preps US FDA Commissioner Nominee For Confirmation

HELP Committee members pepper Martin Makary with questions about his investments and potential conflicts of interest as commissioner. Makary’s transparency extends to saying FDA should “use common sense to ask some big questions we've never asked before,” including making more medical products available OTC.

Senate HELP Committee members question FDA commissioner nominee Martin Makary on 6 March. (Screenshot of Senate Broadcast)

Transparency from US Food and Drug Administration commissioner nominee Martin Makary extends to telling Senate members that the agency should “use common sense to ask some big questions we’ve never asked before,” including making more medical products available OTC.

Health, Education, Labor and Pensions Committee members, on 6 March during a confirmation hearing, peppered Makary, a physician who specializes in surgical oncological physician and is chief of pancreatic islet transplant surgery at Johns Hopkins University School of Medicine, with questions on

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Leadership

More from HBW Insight